CADRE HOLDINGS, INC.

CDRE

CIK 0001860543 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$167M
↓-5.0% -$9Mvs FY2024 (Q4)
Operating Income
$20M
↓-30.5% -$9Mvs FY2024 (Q4)
Net Income
$12M
↓-9.6% -$1Mvs FY2024 (Q4)
Gross Profit
$73M
↓-5.9% -$5Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
45/100
  • Profitability
    17ROIC 8.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.50 (above 1.5 = solid)
  • Leverage
    54D/E 0.92 (under 0.5 = conservative)
  • Efficiency
    51Asset Turnover 0.86x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -5.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    49Op Margin 12.2% · trend -0.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CDRE's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

11%

Trailing 3-yr CAGR was 10.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$25.44
Total enterprise IV
$1.10B
Diluted shares
0.04B
Terminal PV
$813M (74% of total)
Year-5 FCF
$96M
YearProjected FCFDiscounted PV
+1$63M$57M
+2$70M$58M
+3$78M$58M
+4$86M$59M
+5$96M$59M
Terminal$1.31B$813M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$7M
investment in PP&E
Dividends paid (TTM)
$15M
cash returned to holders
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$770M
everything owned
Total liabilities
$452M
everything owed
Stockholders' equity
$318M
shareholder claim
Net debt
$168M
LT debt minus cash

Recent performance · 24 quarters

Revenue↓-5.0% -$9M
$167M
Net Income↓-9.6% -$1M
$12M
Free Cash Flow↓-19.8% -$4M
$18M
Operating Margin↓-4.5pts
12.2%

Drill down